首页> 美国卫生研究院文献>Marine Drugs >Bioactivity Assessment of Indian Origin—Mangrove Actinobacteria against Candida albicans
【2h】

Bioactivity Assessment of Indian Origin—Mangrove Actinobacteria against Candida albicans

机译:印度血统的生物活性评估-针对白色念珠菌的红树林放线菌。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Actinobacteria is found to have a potent metabolic activity against pathogens. The present study reveals the assessment of potent antifungal secondary metabolites from actinobacteria isolated from Indian marine mangrove sediments. The samples were collected from the coastal regions of Muthupet, Andaman and the Nicobar Islands. Identification was carried out using 16S rRNA analysis and biosynthetic genes (Polyketide synthase type I/II and Non-ribosomal peptide synthase) were screened. Actinobacteria were assayed for their antifungal activity against 16 clinical Candida albicans and the compound analysis was performed using gas chromatography-mass spectrometry GC-MS. The 31 actinobacterial strains were isolated and 16S rRNA gene sequencing revealed that this ecosystem is rich on actinobacteria, with Streptomyces as the predominant genus. The PCR based screening of biosynthetic genes revealed the presence of PKS-I in six strains, PKS-II in four strains and NRPS in 11 strains. The isolated actinobacteria VITGAP240 and VITGAP241 (two isolates) were found to have a potential antifungal activity against all the tested C. albicans. GC-MS results revealed that the actinobacterial compounds were belonging to heterocyclic, polyketides and peptides. Overall, the strains possess a wide spectrum of antifungal properties which affords the production of significant bioactive metabolites as potential antibiotics.
机译:发现放线菌对病原体具有有效的代谢活性。本研究揭示了从印度海洋红树林沉积物中分离出的放线菌中有效的抗真菌次生代谢产物的评估。样品是从Muthupet,安达曼和尼科巴群岛的沿海地区收集的。使用16S rRNA分析进行鉴定,并筛选生物合成基因(I / II型多聚酮合酶和非核糖体肽合酶)。测定放线菌对16种临床白色念珠菌的抗真菌活性,并使用气相色谱-质谱GC-MS进行化合物分析。分离出31株放线菌,对16S rRNA基因进行测序后发现,该生态系统富含放线菌,以链霉菌为主要属。基于PCR的生物合成基因的筛选揭示了六种菌株中PKS-I的存在,四种菌株中PKS-II的存在以及11种菌株中的NRPS的存在。发现分离的放线菌VITGAP240和VITGAP241(两个分离株)对所有测试的白色念珠菌均具有潜在的抗真菌活性。 GC-MS结果表明,放线菌化合物属于杂环化合物,聚酮化合物和肽。总体而言,该菌株具有广泛的抗真菌特性,可提供重要的生物活性代谢产物作为潜在的抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号